70.32
Overview
News
Price History
Option Chain
Financials
Why CTVA Down?
Discussions
Forecast
Dividend History
Corteva Inc stock is traded at $70.32, with a volume of 2.44M.
It is down -0.13% in the last 24 hours and up +14.23% over the past month.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
See More
Previous Close:
$70.41
Open:
$70.49
24h Volume:
2.44M
Relative Volume:
0.72
Market Cap:
$47.97B
Revenue:
$16.83B
Net Income/Loss:
$1.14B
P/E Ratio:
42.88
EPS:
1.64
Net Cash Flow:
$2.10B
1W Performance:
+1.97%
1M Performance:
+14.23%
6M Performance:
+12.51%
1Y Performance:
+26.34%
Corteva Inc Stock (CTVA) Company Profile
Name
Corteva Inc
Sector
Industry
Phone
(833) 267-8382
Address
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CTVA
Corteva Inc
|
70.32 | 47.04B | 16.83B | 1.14B | 2.10B | 1.64 |
![]()
NTR
Nutrien Ltd
|
59.56 | 29.09B | 25.68B | 527.00M | 839.00M | 1.07 |
![]()
CF
Cf Industries Holdings Inc
|
91.53 | 14.48B | 6.13B | 1.34B | 1.86B | 7.59 |
![]()
MOS
Mosaic Company
|
36.03 | 11.27B | 11.06B | 367.80M | 212.50M | 1.16 |
![]()
ICL
Icl Group Ltd
|
6.64 | 8.34B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-31-25 | Upgrade | Argus | Hold → Buy |
Mar-13-25 | Initiated | Goldman | Buy |
Oct-23-24 | Initiated | Citigroup | Buy |
Oct-16-24 | Upgrade | BofA Securities | Neutral → Buy |
Aug-07-24 | Downgrade | Argus | Buy → Hold |
Apr-12-24 | Downgrade | JP Morgan | Overweight → Neutral |
Mar-01-24 | Initiated | Wolfe Research | Outperform |
Feb-12-24 | Upgrade | Loop Capital | Hold → Buy |
Feb-02-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Nov-27-23 | Downgrade | Berenberg | Buy → Hold |
Nov-14-23 | Downgrade | Barclays | Overweight → Equal Weight |
Oct-20-23 | Upgrade | Oppenheimer | Perform → Outperform |
Sep-05-23 | Upgrade | UBS | Neutral → Buy |
Jul-25-23 | Downgrade | Redburn | Buy → Neutral |
Jun-28-23 | Initiated | Canaccord Genuity | Buy |
May-22-23 | Upgrade | Vertical Research | Hold → Buy |
Apr-06-23 | Initiated | Oppenheimer | Perform |
Jan-19-23 | Initiated | Wells Fargo | Overweight |
Jan-11-23 | Upgrade | BofA Securities | Underperform → Neutral |
Nov-16-22 | Downgrade | UBS | Buy → Neutral |
Nov-15-22 | Downgrade | Loop Capital | Buy → Hold |
Aug-08-22 | Upgrade | JP Morgan | Neutral → Overweight |
Aug-08-22 | Upgrade | ROTH Capital | Neutral → Buy |
Jul-14-22 | Initiated | Credit Suisse | Outperform |
Jun-01-22 | Initiated | Barclays | Overweight |
May-06-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-14-22 | Upgrade | Loop Capital | Hold → Buy |
Apr-14-22 | Downgrade | Vertical Research | Buy → Hold |
Jan-31-22 | Upgrade | Redburn | Neutral → Buy |
Oct-18-21 | Downgrade | Loop Capital | Buy → Hold |
Oct-13-21 | Initiated | Mizuho | Buy |
Oct-08-21 | Initiated | ROTH Capital | Buy |
Sep-01-21 | Initiated | Berenberg | Buy |
Aug-09-21 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
May-10-21 | Downgrade | BofA Securities | Buy → Underperform |
Apr-19-21 | Upgrade | Loop Capital | Hold → Buy |
Feb-05-21 | Upgrade | JP Morgan | Neutral → Overweight |
Feb-05-21 | Reiterated | Monness Crespi & Hardt | Sell |
Dec-18-20 | Downgrade | Susquehanna | Positive → Neutral |
Dec-14-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-10-20 | Upgrade | Argus | Hold → Buy |
Oct-19-20 | Upgrade | BofA Securities | Neutral → Buy |
Oct-19-20 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
Aug-11-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Aug-10-20 | Downgrade | BofA Securities | Buy → Neutral |
Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
Jun-26-20 | Initiated | Cleveland Research | Neutral |
Jun-16-20 | Upgrade | Vertical Research | Hold → Buy |
Jun-08-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
May-11-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
Apr-17-20 | Downgrade | BofA/Merrill | Buy → Neutral |
Apr-17-20 | Upgrade | Loop Capital | Sell → Hold |
Apr-01-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Mar-31-20 | Upgrade | Susquehanna | Neutral → Positive |
Mar-26-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
Mar-19-20 | Upgrade | Edward Jones | Hold → Buy |
Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
Mar-10-20 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
View All
Corteva Inc Stock (CTVA) Latest News
Class Counsel Get $6M Fees In Corteva Benefits Info Suit - Law360
Berenberg Adjusts Price Target on Corteva to $60 From $59, Maintains Hold Rating - marketscreener.com
$100 Invested In Corteva 5 Years Ago Would Be Worth This Much Today - Benzinga
Corteva Announces Dates for Second Quarter 2025 Earnings Release and Webcast | CTVA Stock News - GuruFocus
Corteva Announces Dates for Second Quarter 2025 Earnings Release and Webcast - Longview News-Journal
Crop Protection Chemicals Market Outlook 2025-2032: Growth - openPR.com
Corteva Inc.: Advancements in Global Agricultural Technologies - Smartkarma
Corteva, Inc. : Focusing on tomorrow's food - marketscreener.com
Corteva's (NYSE:CTVA) investors will be pleased with their impressive 168% return over the last five years - Yahoo Finance
Corteva’s SWOT analysis: agricultural innovation drives stock outlook - Investing.com Australia
DuPont, Chemours and Corteva Will Pay Ohio $110 Million in Settlement Over “Forever” Chemicals - Cleveland Scene
Corteva stock soars to all-time high of $69.3 amid robust growth By Investing.com - Investing.com South Africa
Corteva stock soars to all-time high of $69.3 amid robust growth - Investing.com Australia
Corteva and DuPont announce multi-million dollar expansions - theheraldreview.com
Corteva: AI can transform crop protection to replace ‘randomness and chance’ with ‘prediction, specificity and design' - AgFunderNews
Mark Cuban Foundation and Corteva Bring Free AI Bootcamp to Indianapolis, Des Moines Area Teens - The Manila Times
Redburn Atlantic Adjusts Price Target on Corteva to $68 From $66, Maintains Neutral Rating - marketscreener.com
Senior VP Of Corteva Sold 27% Of Their Shares - simplywall.st
Corteva Appeal Over Bayer Corn Paused for High Court Patent Case - Bloomberg Law News
Corteva Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Corteva Phases Out BMR, Introduces TonnEdge - Dairy Herd
Analysts Conflicted on These Materials Names: Kinross Gold (KGC) and Corteva (CTVA) - The Globe and Mail
Corteva at BMO Global Farm to Market: Strategic Growth and Innovation - Investing.com Nigeria
Expert Outlook: Corteva Through The Eyes Of 10 Analysts - Benzinga
Judge Allows Inari to Raise ‘Unclean Hands’ in Corteva Seed Case - Bloomberg Law News
Conner Prairie and Corteva announces strategic partnership to highlight agriculture innovation - Greensburg Daily News
Corteva, Bayer Clash on Corn Royalties Tied to Brazil Patent (1) - Bloomberg Law News
Transcript : Corteva, Inc. Presents at 2025 BMO Farm to Market | Chemicals Conference, May-14-2025 08 - marketscreener.com
JPMorgan Adjusts Price Target on Corteva to $65 From $60, Maintains Neutral Rating - marketscreener.com
Barclays Adjusts Price Target on Corteva to $70 From $64, Maintains Equalweight Rating - marketscreener.com
Agritech Market Global Outlook & Forecast Report 2025-2030, Competitive Analysis of AGCO, Bayer Crop Science, CNH Industrial, Corteva Agriscience, John Deere, Kubota, Syngenta, and TrimbleResearchAndMarkets.com | FinancialContent - FinancialContent
Corteva To Present At 2025 BMO Global Farm To Market Conference; Webcast At 8:45 AM ET - Nasdaq
Barclays Ups Price Target for Corteva (CTVA) Amidst Strong Ferti - GuruFocus
Barclays Ups Price Target for Corteva (CTVA) Amidst Strong Fertilizer Demand | CTVA Stock News - GuruFocus
Corteva price target raised to $70 from $64 at Barclays - TipRanks
Wells Fargo & Company Boosts Corteva (NYSE:CTVA) Price Target to $79.00 - Defense World
Corteva stock price target raised to $73 at BofA Securities By Investing.com - Investing.com Canada
Corteva stock price target raised to $73 at BofA Securities - Investing.com Australia
Diquat Dibromide Market Growth | Trends, Forecast & Top - openPR.com
Deutsche Bank Adjusts Corteva Price Target to $78 From $70, Maintains Buy Rating - marketscreener.com
Corteva Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Corteva Announces Pricing of Senior Notes Offering | CTVA Stock News - GuruFocus
Wells Fargo Increases Price Target for Corteva (CTVA) Amid Positive Outlook | CTVA Stock News - GuruFocus
Corteva subsidiary prices $500M senior notes offering By Investing.com - Investing.com Nigeria
Corteva Inc Stock (CTVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):